|Bid||86.70 x 800|
|Ask||86.72 x 2900|
|Day's Range||85.18 - 90.32|
|52 Week Range||35.25 - 123.31|
|Beta (5Y Monthly)||1.90|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct. 27, 2020 - Nov. 02, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||116.50|
EXAS earnings call for the period ending June 30, 2020.
Exact Sciences' (EXAS) legacy screening business sees a decline in revenues in Q2 earnings.
Health screening company Exact Sciences CEO Kevin Conroy speaks with Yahoo Finance’s Alexis Christoforous, Brian Sozzi and Anjalee Khemlani